photo taken from Antonio Marra/Twitter
Mar 23, 2024, 23:31
Antonio Marra: Our review on current use and future development of PARP inhibitors in breast cancer just out in JAMA Oncology
Antonio Marra, Medical Oncologist at the European Institute of Oncology, on LinkedIn:
“Excited to see our review on current use and future development of PARP inhibitors in breast cancer just out in JAMA Oncology
Many steps have been made in the last 20 yrs, a vast amount is left waiting to be explored
- Patient population who may benefit from PARPi
- New drugs (e.g., PARP1-selective) to reduce toxicity
- Novel combos with IO and ADCs
Amazing collaboration with many Italian and American colleagues and friends Stefania Morganti, Carmen Criscitiello, Giuseppe Curigliano, Carmine De Angelis, Giampaolo Bianchini, Luca Licata, Angela Esposito, IEO Istituto Europeo di Oncologia, Dana-Farber Cancer Institute.”
Read further.
Source: Antonio Marra/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14